Human Facing the Dangerous Day for Multidrug Resistant Organisms or Antibiotic Resistant At Present and Future

Ikram Hasan
Additional contact information
Ikram Hasan: Department of pharmacy, Begum Gulchemonara Trust University, Bangladesh

Current Trends in Biomedical Engineering & Biosciences, 2017, vol. 1, issue 2, 50-52

Abstract: Multi-drug resistance organism are very clever and gradually resistant the most antibiotic. Now a days maximum antibiotic such as penicillin, cephalosporins, aminoglycosides, tetracyclines, macrolides etc. group resisted by microorganism. Esch. coli resistant the antibiotic such as amoxicillin, cotrimoxazole, cephalexin, cepharadine, ceftriaxone, ceftrazidime, ciprofloxacin, nalidixic acid and Coliform bacteria resistant the antibiotic such as azithroycin, ceftrioxane, cefepime, doxycycline, gentamycin, nitrofurantion and Acinetobacter species resistant the antibiotic such as amoxicillin, amoxicillin/clav, cephadine, cefuroxime, ceftriaxone, cefixime, ceftazidime, aztreonam, ciprofloxacin, levofloxacin, amikacin, netilmicin, imipenem, meropenem, mecillinam, nitrofurantoin, cotrimoxazole. Many infectious diseases could not relief by single antibiotic and many people have died due to antibiotic resistance and need the double or triple types antibiotic drug for relief the diseases. Antibiotic resistance are very dangerous for surgical patients. If the patients affected by microorganism during operation or after operation of the patients then the life of the patients may be critical even death. At this time the doctor cannot permission the patients for operation or the doctor are afraid for permission of the patients for operation. If the new antibiotic do not discovery or invention then the human life become dangerous even death. After 20-40 years later 90-95% antibiotic will be resist by microorganism all around the world.

Keywords: juniper publishers group; juniper publishers Biomedical Engineering journals; Biomedical Engineering journals list; medical devices journals; peer reviewed Biomedical Engineering journals; open access Biomedical Engineering journals; Biomedical Engineering journals impact factor; Biomedical Engineering scientific journals; Biomedical Engineering articles; scholarly Biomedical Engineering journals; juniper publishers reivew (search for similar items in EconPapers)
Date: 2017
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/ctbeb/pdf/CTBEB.MS.ID.555560.pdf (application/pdf)
https://juniperpublishers.com/ctbeb/CTBEB.MS.ID.555560.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jctbeb:v:1:y:2017:i:2:p:50-52

DOI: 10.19080/CTBEB.2017.01.555560

Access Statistics for this article

Current Trends in Biomedical Engineering & Biosciences is currently edited by Sophia Mathis

More articles in Current Trends in Biomedical Engineering & Biosciences from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().